GlassScriptPhysician profile
Eddie Richardson
NPI 1235107772
$1,200.25
in general payments reported to CMS, 2019-2025
20 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $72.18 · 2021: $85.46 · 2022: $156 · 2023: $146 · 2024: $212 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $153.49 | 2025 | Repatha, Otezla |
| Novo Nordisk INC | $140.78 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $137.42 | 2019-2024 | Mounjaro |
| Dexcom, INC. | $95.84 | 2022-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $89.00 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Astellas Pharma US INC | $83.90 | 2023-2024 | Veozah, Myrbetriq |
| Scilex Pharmaceuticals INC. | $56.72 | 2019 | |
| Indivior INC. | $56.66 | 2019 | |
| Kaleo, INC. | $52.66 | 2019 | |
| Abbvie INC. | $47.10 | 2022-2023 | |
| Exact Sciences Corporation | $44.30 | 2023-2025 | Cologuard Collection Kit |
| Ultragenyx Pharmaceutical INC. | $39.42 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $36.19 | 2019 | |
| Pfizer INC. | $29.08 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $27.68 | 2025 | Rexulti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.74 | 2019 | |
| Evofem Biosciences, INC. | $24.38 | 2022 | |
| Glaxosmithkline, LLC. | $22.93 | 2021 | |
| Vital Connect, INC | $19.70 | 2024 | Vitalpatch Rtm |
| E.R. Squibb & Sons, L.L.C. | $18.26 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddie Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.